top
Search terms
Results 1 - 10 of 22 - ordered by :
Pages: 1 2 3
Eurointervention

EuroIntervention Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score Department for Coagulation Disorders, Skane ...

Date : 26/10/2012 Item size : 35329 bytes
Eurointervention

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. Dewilde W., Ten Berg JM, Trial design: WOEST Trial: What is the Optimal antiplatElet & ...

Date : 15/01/2010 Item size : 35995 bytes
Ehjournal

Atrial fibrillation (AF) is the most common sustained arrhythmia being present in 1.52% of the population and has been found to occur more frequently in oncology patients.1 Cancer and cancer therapy ...

European Heart Journal, CardioPulse, José L Zamorano

Date : 21/09/2016 Item size : 127251 bytes
Ehjournal

If a VKA is used, good quality anticoagulation control, defined as a time in therapeutic range (TTR) >70%, is crucial, given that the efficacy and (particularly) safety of VKA is intimately related ...

European Heart Journal, Editorial, Gregory Y.H. Lip, Deirdre A. Lane

Date : 07/12/2015 Item size : 179987 bytes
Epeuropace

Warfarin, the most commonly applied VKA, reduces the stroke risk by 64%.1 The major drawbacks of VKA therapy include the risk of bleeding, especially intracranial haemorrhage, many food and drugdrug ...

Europace, Review, T. Lewalter, P. Kanagaratnam, B. Schmidt, M. Rosenqvist, J. E. Nielsen-Kudsk, R. Ibrahim, B. A. Albers, A. J. Camm

Date : 01/05/2014
Epeuropace

Abstract This EP Wire surveyed clinical practice with regard to the use of antithrombotic therapy in relation to device implantation (pacemakers, ICT, resynchronization therapy) and atrial ...

Europace, EP WIRE, Gregory Y.H. Lip, Alessandro Proclemer, Nikolaus Dagres, Maria Grazia Bongiorni, Thorsten Lewalter, Carina Blomstrom-Lundqvist

Date : 01/05/2012
Epeuropace

Randomized trials in patients with atrial fibrillation (AF) have consistently demonstrated that compared with placebo, adjusted-dose vitamin K antagonists (VKAs) reduce the incidence of stroke by ...

Europace, Editorial, Laurent Fauchier, Gregory Y.H. Lip

Date : 01/06/2010
Ehjournal

Prof. Gregory Lip discusses how to keep the decision-making process for choosing an oral anticoagulant simple and practical Stroke prevention is the cornerstone of the management of atrial ...

European Heart Journal, CardioPulse, Gregory Y. H. Lip

Date : 01/01/2017
Ehjournal

Prof. Gregory Lip discusses how to keep the decision-making process for choosing an oral anticoagulant simple and practical Stroke prevention is the cornerstone of the management of atrial ...

European Heart Journal, Lip, Gregory Y. H.

Date : 01/01/2017
Ehjournal

Currently, the optimal combination of anticoagulants and anti-platelet therapy is unknown, but it is well established that the combination of regular doses and regimens as prescribed in AF or after ...

European Heart Journal, Moser, Martin, Olivier, Christoph B., Bode, Christoph

Date : 21/01/2014 Item size : 382265 bytes